Novo Nordisk A/S | NOVOB - Interest Expense On Debt

Stock Price
248.30
Daily Change
1.25 0.51%
Monthly
-19.88%
Yearly
-54.46%
Q1 Forecast
234.25

Novo Nordisk reported DKK1.53B in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Bausch Health Companies USD 412M 53M Sep/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Merck USD 412M 85M Dec/2025
Novartis USD 281M 8M Sep/2025
Novo Nordisk DKK 1.53B 3.43B Sep/2025
Pacira USD 3.89M 387K Dec/2025
Sanofi EUR -25M 252M Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023